How to Treat Hormone Receptor Positive Cancer - Latest Advancements and Current Standard of Care in 2025

Welcome to the Oncology Brothers podcast! In this episode, Drs. Rahul and Rohit Gosain are joined by Dr. Kevin Kalinsky, a leading breast medical oncologist and director of the breast cancer program at the Winship Cancer Institute of Emory University.

Join us as we dive deep into the complexities of hormone receptor-positive breast cancer treatment. We discuss the latest advancements in treatment algorithms, including the use of OncotypeDX in premenopausal versus postmenopausal women, the role of ovarian function suppression, and the implications of new approvals like Inavolisib and CDK4-6 inhibitors.

Key topics covered in this episode:
•⁠  ⁠The significance of recurrence scores in dictating adjuvant chemotherapy
•⁠  ⁠The ongoing OFSET trial and its potential impact on treatment decisions
•⁠  ⁠Insights into the use of genomic assays like MammaPrint and RS-Clin
•⁠  ⁠The evolving landscape of treatment options for locally advanced and metastatic breast cancer
•⁠  ⁠The latest on PARP inhibitors, T-DXd, and other novel therapies

Whether you're a medical professional or someone interested in the latest in oncology, this episode is packed with valuable insights and clinical pearls. Don't forget to subscribe for more discussions on cancer treatment, FDA approvals, and conference highlights!

YouTube: https://youtu.be/_icBN3J3Bc0

Follow us on social media:
•⁠  ⁠X/Twitter: https://twitter.com/oncbrothers
•⁠  ⁠Instagram: https://www.instagram.com/oncbrothers

#OncologyBrothers #HR+ #breastcancer   #HormoneReceptorPositiveCancer #oncbrothers  #Podcast